Dupont De Nemours Inc SEC Filings

Insider purchase via dividend reinvestment: Director Frederick M. Lowery acquired 503.7702 shares of DuPont de Nemours, Inc. (DD) on 08/29/2025 at a reported price of $76.92 per share, increasing his direct beneficial ownership to 33,270.0198 shares. The filing notes the acquisition includes shares purchased through a dividend reinvestment program. The Form 4 was signed by Peter W. Hennessey by power of attorney on 09/03/2025.

Cutler Alexander M, identified as a Director of DuPont de Nemours, Inc. (Ticker: DD), reported a purchase of 650.026 shares of DuPont common stock on 08/29/2025 at a price of $76.92 per share. The filing states the acquisition includes shares received through dividend reinvestment.

After this transaction, Mr. Cutler is reported to beneficially own 73,879.0062 shares in a direct ownership form. The Form 4 was signed by power of attorney on 09/03/2025 by Peter W. Hennessey.

Terrence R. Curtin, a director of DuPont de Nemours, Inc. (DD), reported an open-market acquisition on 08/29/2025. The Form 4 shows he acquired 422.5169 shares of DuPont common stock at a price of $76.92 per share, with the filing noting the acquisition includes shares received through dividend reinvestment. After the transaction, Mr. Curtin beneficially owned 30,966.5213 shares in total, including 7,500 shares held indirectly through family trusts.

The Form 4 was signed by Peter W. Hennessey by power of attorney on 09/03/2025. The filing lists Mr. Curtin's address in Wilmington, DE, and identifies his relationship to the issuer as a director.

Amy G. Brady, a director of DuPont de Nemours, Inc. (DD), reported a non-derivative purchase of common stock on 08/29/2025. The Form 4 shows an acquisition of 105.6292 shares at a price of $76.92 per share, bringing her total reported beneficial ownership to 19,274.5372 shares, held directly. The filing includes a disclosure that the total includes shares acquired through dividend reinvestment. The filing was submitted with a signature dated 09/03/2025 by Peter W. Hennessey by power of attorney.

DuPont announced a definitive agreement to sell its Aramids business (Kevlar4 and Nomex4) to Arclin for an enterprise value of approximately $1.8 billion. Under the Transaction Agreement, DuPont will receive roughly $1.2 billion in pre-tax cash at closing (subject to customary adjustments), a $300 million note receivable, and a non-controlling common equity stake in the combined Arclin business currently valued at $325 million, expected to represent about a 17.5% ownership at closing. The agreement is conditioned on customary closing requirements, including regulatory approvals in multiple non-U.S. jurisdictions and satisfactory representations, warranties and performance by the parties.

DuPont agreed to sell its Aramids business (Kevlar® and Nomex®) to Arclin, a portfolio company of an affiliate of TJC, L.P., in a transaction valuing the business at approximately $1.8 billion. At closing DuPont is expected to receive approximately $1.2 billion in pre-tax cash proceeds (subject to customary adjustments), a $300 million note receivable, and a non-controlling common equity stake in the combined Arclin business currently valued at about $325 million (approximately 17.5% at closing). The sale is conditioned on customary closing conditions, including regulatory approvals. The information is disclosed in a press release embedded in the company’s 8-K filing.

Edward D. Breen, Executive Chair and director of DuPont de Nemours (DD), reported changes in his beneficial ownership of common stock. On 08/12/2025 he received 13,754 shares as annuity payments from prior 2021 GRATs and through dividend reinvestment, bringing his post-transaction holdings to 165,405.7751 shares. On 08/20/2025 he recorded a disposition of 28,111 shares related to funding a new GRAT (2025-7), leaving 137,294.7511 shares beneficially owned. The filing notes the 13,754 shares were received at no cash price and the 28,111 shares were disposed of at no cash price. The report was submitted by power of attorney.

DuPont de Nemours (DD) filed an 8-K describing contingent outcomes tied to a planned Spin-Off involving Qnity. The filing states that if the Spin-Off is not consummated by the earlier of March 31, 2026 or the date Qnity notifies parties that the Spin-Off will not occur, or if not completed within two business days of gross proceeds being released from escrow, then the Notes will be subject to a special mandatory redemption. The filing also states that the Unsecured Notes will be jointly and severally and unconditionally guaranteed on a senior unsecured basis by each Qnity subsidiary that is a borrower or guarantor under Qnity's Credit Facilities. The document is signed by Michael G. Goss, Vice President and Controller, dated August 15, 2025.

DuPont de Nemours announced that its wholly owned subsidiary, Qnity Electronics, priced an offering of debt securities consisting of $1.0 billion aggregate principal amount of 5.750% Senior Secured Notes due 2032 and $750 million aggregate principal amount of 6.250% Senior Notes due 2033. The Notes were priced at 100.000% of their principal amount and are being offered under Rule 144A and Regulation S.

The offering is being made in connection with DuPont's previously announced plan to separate its electronics business through a pro rata distribution of Qnity common stock to DuPont stockholders. The offering is expected to close on August 15, 2025, subject to customary closing conditions, and the Notes and related guarantees have not been registered under the Securities Act.